The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of multicenter phase II WSG Neo-Predict trial: Predictive markers for evaluation of response to neoadjuvant paclitaxel+trastuzumab+lapatinib in HER2-positive early breast cancer.
 
Christian Eichler
No Relationships to Disclose
 
Oleg Gluz
Honoraria - NanoString Technologies
Consulting or Advisory Role - Genomic Health International; Roche Pharma AG
Travel, Accommodations, Expenses - Celgene
 
Ulrike Nitz
Consulting or Advisory Role - Genomic Health; Roche Pharma AG
 
Matthias Christgen
No Relationships to Disclose
 
Petra Krabisch
No Relationships to Disclose
 
Reinhard Hackenberg
No Relationships to Disclose
 
Markus Skrobol
Honoraria - Roche
 
Volker Möbus
No Relationships to Disclose
 
Ronald Kates
No Relationships to Disclose
 
Johannes Schumacher
No Relationships to Disclose
 
Hans Heinrich Kreipe
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG
 
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Hexal; Novartis; Pfizer; Roche/Genentech; Sandoz
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Mathias Warm
Travel, Accommodations, Expenses - Celgene